This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (84)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Statistics and Research Methods  • Conflict of Interest  • Medical Ethics  • Alert me on articles by topic

Mildred K. Cho, PhD; Ryo Shohara; Anna Schissel, MBioethics; Drummond Rennie, MD

JAMA. 2000;284:2203-2208.

Context  Despite federal regulations on faculty conflicts of interest in federally funded research, academic-industry ties are common, and evidence exists that financial considerations bias the research record. Public scrutiny of these ties is increasing, especially in cases where researchers have financial interests in the corporate sponsors of their clinical research.

Objective  To review policies on conflict of interest at major biomedical research institutions in the United States.

Design  Cross-sectional survey and content analysis study conducted from August 1998 to February 2000.

Setting and Participants  The 100 US institutions with the most funding from the National Institutes of Health in 1998 were initially sampled; policies from 89 institutions were available and included in the analysis.

Main Outcome Measures  Process for disclosure, review, and management of conflicts of interest and specified management strategies or limitations, according to the institutions' faculty/staff conflict of interest policies.

Results  Content of the conflict of interest policies varied widely across institutions. Fifty-five percent of policies (n = 49) required disclosures from all faculty while 45% (n = 40) required them only from principal investigators or those conducting research. Nineteen percent of policies (n = 17) specified limits on faculty financial interests in corporate sponsors of research, 12% (n = 11) specified limits on permissible delays in publication, and 4% (n = 4) prohibited student involvement in work sponsored by a company in which the faculty mentor had a financial interest.

Conclusions  Most policies on conflict of interest in our sample of major research institutions in the United States lack specificity about the kinds of relationships with industry that are permitted or prohibited. Wide variation in management of conflicts of interest among institutions may cause unnecessary confusion among potential industrial partners or competition among universities for corporate sponsorship that could erode academic standards. It is in the long-term interest of institutions to develop widely agreed-on, clear, specific, and credible policies on conflicts of interest.

Author Affiliations: Stanford University Center for Biomedical Ethics, Stanford, Calif (Dr Cho); University of California, San Francisco, Institute for Health Policy Studies (Mr Shohara and Dr Rennie); and New York University School of Law, New York, NY (Ms Schissel). Dr Rennie is also Deputy Editor, JAMA.

RELATED ARTICLES

Financial Indigestion
Jerome P. Kassirer
JAMA. 2000;284(17):2156-2157.
EXTRACT | FULL TEXT  

Evaluation of HIV-1 Immunogen, an Immunologic Modifier, Administered to Patients Infected With HIV Having 300 to 549 x 10⁶/L CD4 Cell Counts: A Randomized Controlled Trial
James O. Kahn, Deborah Weng Cherng, Kenneth Mayer, Henry Murray, Stephen Lagakos, and for the 806 Investigator Team
JAMA. 2000;284(17):2193-2202.
ABSTRACT | FULL TEXT  

Assessing Faculty Financial Relationships With Industry: A Case Study
Elizabeth A. Boyd and Lisa A. Bero
JAMA. 2000;284(17):2209-2214.
ABSTRACT | FULL TEXT  

Conflicts of Interest in Biomedical Research
David Korn
JAMA. 2000;284(17):2234-2237.
EXTRACT | FULL TEXT  

Conflict of Interest and the Public Trust
Catherine D. DeAngelis
JAMA. 2000;284(17):2237-2238.
EXTRACT | FULL TEXT  

November 1, 2000
JAMA. 2000;284(17):2257-2258.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Disclosure of conflicts of interest in biomedical publications/La declaration de conflits d'interet dans les publications biomedicales
Miller
Canadian J. Anesthesia 2008;55:265-269.
FULL TEXT  

A Turning Point for Conflicts of Interest: The Controversy Over the National Academy of Sciences' First Conflicts of Interest Disclosure Policy
Parascandola
JCO 2007;25:3774-3779.
ABSTRACT | FULL TEXT  

The Legal and Ethical Issues Surrounding Financial Conflict of Interest in Orthopaedic Research
Okike and Kocher
JBJS 2007;89:910-913.
FULL TEXT  

Symposium. Relationships with Industry: Critical for New Technology or an Unnecessary Evil?
Jacobs et al.
JBJS 2006;88:1650-1663.
FULL TEXT  

Informed Trust and the Financing of Biomedical Research
Sharp and Yarborough
J Law Med Ethics 2006;34:460-464.
 

Regulating Academic-Industrial Research Relationships -- Solving Problems or Stifling Progress?
Stossel
NEJM 2005;353:1060-1065.
FULL TEXT  

The Contract Research Organization and the Commercialization of Scientific Research
Mirowski and Van Horn
Social Studies of Science 2005;35:503-548.
ABSTRACT  

Oversight of Human Participants Research: Identifying Problems To Evaluate Reform Proposals
Emanuel et al.
ANN INTERN MED 2004;141:282-291.
ABSTRACT | FULL TEXT  

How Can We Help? From "Sociology in" to "Sociology of" Bioethics
De Vries
J Law Med Ethics 2004;32:279-292.
 

Inside Information: Financial Conflicts of Interest for Research Subjects in Early Phase Clinical Trials
Helft et al.
JNCI J Natl Cancer Inst 2004;96:656-661.
ABSTRACT | FULL TEXT  

Potential research participants' views regarding researcher and institutional financial conflicts of interest
Kim et al.
J. Med. Ethics 2004;30:73-79.
ABSTRACT | FULL TEXT  

Academic-Industrial Relationships in the Life Sciences
Blumenthal
NEJM 2003;349:2452-2459.
FULL TEXT  

Media Coverage of Conflicts of Interest in Science
McComas and Simone
Science Communication 2003;24:395-419.
ABSTRACT  

How to dance with porcupines: rules and guidelines on doctors' relations with drug companies
Wager
BMJ 2003;326:1196-1198.
FULL TEXT  

The "Price" of Information
Heinig
J Hum Lact 2003;19:133-135.
 

Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review
Bekelman et al.
JAMA 2003;289:454-465.
ABSTRACT | FULL TEXT  

Nonfinancial Conflicts of Interest in Research
Sollitto et al.
NEJM 2002;347:2173-2173.
FULL TEXT  

A National Survey of Provisions in Clinical-Trial Agreements between Medical Schools and Industry Sponsors
Schulman et al.
NEJM 2002;347:1335-1341.
ABSTRACT | FULL TEXT  

Working with the private sector: the need for institutional guidelines
Walt et al.
BMJ 2002;325:432-435.
FULL TEXT  

From Clinical Trial to Prescription
Carpenter
Arch Gen Psychiatry 2002;59:282-285.
ABSTRACT | FULL TEXT  

Legal Issues in Scientific Research
Kalb and Koehler
JAMA 2002;287:85-91.
ABSTRACT | FULL TEXT  

Attacks on Science: The Risks to Evidence-Based Policy
Rosenstock and Lee
Am. J. Public Health 2002;92:14-18.
ABSTRACT | FULL TEXT  

Colloid Use for Fluid Resuscitation: Evidence and Spin
Cook and Guyatt
ANN INTERN MED 2001;135:205-208.
FULL TEXT  

Reporting Financial Conflicts of Interest and Relationships Between Investigators and Research Sponsors
DeAngelis et al.
JAMA 2001;286:89-91.
FULL TEXT  

Drugs and Therapeutics in the Age of the Genome
Etkin
JAMA 2000;284:2786-2787.
FULL TEXT  

To Protect Those Who Serve
Drazen and Koski
NEJM 2000;343:1643-1645.
FULL TEXT  

In Whose Best Interest? Breaching the Academic-Industrial Wall
Martin and Kasper
NEJM 2000;343:1646-1649.
FULL TEXT  

Conflicts of Interest in Biomedical Research
Korn
JAMA 2000;284:2234-2237.
FULL TEXT  

Conflict of Interest and the Public Trust
DeAngelis
JAMA 2000;284:2237-2238.
FULL TEXT